Antimicrobial therapy for bone and joint infections

被引：10

作者：

Aslam S. ^{[1
]}

Darouiche R.O. ^{[1
]}

机构：

[1] Section of Infectious Diseases, Michael E. DeBakey VA Medical Center, Houston, TX 77030

来源：

Current Infectious Disease Reports | 2009年 / 11卷 / 1期

关键词：

Vancomycin; Osteomyelitis; Clindamycin; Linezolid; Rifampin;

D O I：

10.1007/s11908-009-0002-x

中图分类号：

学科分类号：

摘要：

Bone and joint infections present a major therapeutic dilemma for health care providers from different medical and surgical specialties. There is a conspicuous lack of strong data on epidemiologic findings, financial impact related to loss of work, and rehabilitation cost in the area of bone infections. This review outlines the antimicrobial options and duration of therapy for osteomyelitis, prostheses-associated orthopedic infections, and septic arthritis. © Current Medicine Group LLC 2009.

引用

页码：7 / 13

页数：6

共 50 条

[1] A Comparison of Causative Pathogens in Bone and Prosthetic Joint Infections: Implications for Antimicrobial Therapy [J].

Unsworth, Annalise ;

Young, Bernadette ;

Scarborough, Matthew ;

Mcnally, Martin .

ANTIBIOTICS-BASEL, 2024, 13 (12)

[2] Does Bacteremia Associated With Bone and Joint Infections Necessitate Prolonged Parenteral Antimicrobial Therapy? [J].

Paakkonen, Markus ;

Kallio, Pentti E. ;

Kallio, Markku J. T. ;

Peltola, Heikki .

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY, 2015, 4 (02) :174-177

[3] Outpatient parenteral antimicrobial therapy-treated bone and joint infections in a tropical setting [J].

White, H. A. ;

Davis, J. S. ;

Kittler, P. ;

Currie, B. J. .

INTERNAL MEDICINE JOURNAL, 2011, 41 (09) :668-673

[4] Exploring Nanotechnology as a Strategy to Circumvent Antimicrobial Resistance in Bone and Joint Infections [J].

Skosana, Phumzile P. ;

Mudenda, Steward ;

Demana, Patrick H. ;

Witika, Bwalya A. .

ACS OMEGA, 2023, 8 (18) :15865-15882

[5] Bone and Joint Infections [J].

Paakkonen, Markus ;

Peltola, Heikki .

PEDIATRIC CLINICS OF NORTH AMERICA, 2013, 60 (02) :425-+

[6] Clinical Guidelines for the Antimicrobial Treatment of Bone and Joint Infections in Korea [J].

Lee J.-S. ;

Lee J. ;

Choi J.-P. ;

Song J.-Y. ;

Ha C.-W. ;

Lee J.H. ;

Yoo J.J. ;

Yum J.-K. ;

Oh H.-K. ;

In Y. ;

Lee H.-Y. .

INFECTION AND CHEMOTHERAPY, 2014, 46 (02) :125-138

[7] Daptomycin to bone and joint infections and prosthesis joint infections: a systematic review [J].

Telles, Joao Paulo ;

Cieslinski, Juliette ;

Tuon, Felipe Francisco .

BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2019, 23 (03) :191-196

[8] Bacteriophage therapy for bone and joint infections AN INSTRUCTIONAL REVIEW [J].

Gibb, B. P. ;

Hadjiargyrou, M. .

BONE & JOINT JOURNAL, 2021, 103B (02) :234-244

[9] Medicated Hydroxyapatite/Collagen Hybrid Scaffolds for Bone Regeneration and Local Antimicrobial Therapy to Prevent Bone Infections [J].

Mulazzi, Manuela ;

Campodoni, Elisabetta ;

Bassi, Giada ;

Montesi, Monica ;

Panseri, Silvia ;

Bonvicini, Francesca ;

Gentilomi, Giovanna Angela ;

Tampieri, Anna ;

Sandri, Monica .

PHARMACEUTICS, 2021, 13 (07)

[10] Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy [J].

Marks, Michael ;

Bell, Lucy C. K. ;

Jones, Imogen ;

Rampling, Tommy ;

Kranzer, Katharina ;

Morris-Jones, Stephen ;

Logan, Sarah ;

Pollara, Gabriele .

CLINICAL INFECTIOUS DISEASES, 2020, 71 (01) :207-210

← 1 2 3 4 5 →